Please login to the form below

Not currently logged in
Email:
Password:

Ligelizumab

This page shows the latest Ligelizumab news and features for those working in and with pharma, biotech and healthcare.

FDA approves new self-injection administration for Xolair

FDA approves new self-injection administration for Xolair

According to Novartis, ligelizumab binds to IgE with an 88-fold higher affinity than Xolair, with the two binding differently to the antibody. ... Novartis picked up ligelizumab following its acquisition of UK firm Ziarco in 2016.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...